SRC-3/AIB1: Transcriptional coactivator in oncogenesis

Acta Pharmacologica Sinica

Volumn 27, Issue 4, 2006, Pages 387-394

  Yan, Jun ^a   Tsai, Sophia Y ^a   Tsai, Ming Jer ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Mouse model; Oncogene; Signal transduction; SRC 3 AIB1

Indexed keywords

STEROID RECEPTOR COACTIVATOR 3; TRANSCRIPTIONAL COACTIVATOR; UNCLASSIFIED DRUG;

BREAST CANCER; CARCINOGENESIS; CHROMOSOME 20Q; GENE EXPRESSION; HORMONE SENSITIVITY; HUMAN; MULTIPLE CANCER; NONHUMAN; ONCOGENE SRC; ONCOGENE SRC 3; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR MODEL;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; HISTONE ACETYLTRANSFERASES; HUMANS; MALE; ONCOGENES; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 33645237486     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00315.x     Document Type: Review

References (69)

1. Anzick SL Kononen J Walker RL Azorsa DO Tanner MM Guan XY et al. AIB1, a novel estrogen receptor co-activator amplified in breast and ovarian cancer. Science 1997 277 965 8.
2. Torchia J Rose DW Inostroza J Kamei Y Westin S Glass CK et al. The transcriptional coactivator p/CIP binds CBP and me diates nuclear receptor function. Nature 1997 387 677 84.
3. Li H Gomes PJ Chen JD. RAC3 a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad Sci USA 1997 94 8479 84.
4. Chen H Lin RJ Schiltz RL Chakravarti D Nash A Nagy L et al. Nuclear receptor coactivator ACTR is a novel histone acetyl-transferase and forms a multimeric activation complex with p/ CAF and CBP/p300. Cell 1997 90 569 80.
5. Takeshita A Cardona GR Koibuchi N Suen CS Chin WW. TRAM-1, a novel 160 kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J Biol Chem 1997 272 27629 34.
6. Suen CS Berrodin TJ Mastroeni R Cheskis BJ Lyttle CR Frail DE. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. J Biol Chem 1998 273 27645 53.
7. Han SJ Demayo FJ Xu J Tsai SY Tsai MJ O'Malley BW. Steroid receptor coactivators SRC-1 and SRC-3 differentially modulate tissue-specific activation functions of the progester one receptor. Mol Endocrinol 2006 20 45 55.
8. Ying H Furuya F Willingham MC Xu J O'Malley BW Cheng SY. Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone. Mol Cell Biol 2005 25 7687 95.
9. Lee SK Kim HJ Na SY Kim TS Choi HS Im SY et al. Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J Biol Chem 1998 273 16651 4.
10. Werbajh S Nojek I Lanz R Costas MA. RAC-3 is a NF-kappa B coactivator. FEBS Lett 2000 485 195 9.
11. Arimura A Van Peer M Schroder AJ Rothman PB. The transcriptional co-activator p/CIP (NCoA-3) is up-regulated by STAT6 and serves as a positive regulator of transcriptional activation by STAT6. J Biol Chem 2004 279 31105 12.
12. Louie MC Zou JX Rabinovich A Chen HW. ACTR/AIB1functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol 2004 24 5157 71.
13. Chen D Ma H Hong H Koh SS Huang SM Schurter BT et al. Regulation of transcription by a protein methyltransferase. Science 1999 284 2174 7.
14. McKenna NJ O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002 108 465 74.
15. Huang ZJ Edery I Rosbash M. PAS is a dimerization domain common to Drosophila period and several transcription factors. Nature 1993 364 259 62.
16. Belandia B Parker MG. Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J Biol Chem 2000 275 30801 5.
17. Chen SL Dowhan DH Hosking BM Muscat GE. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev 2000 14 1209 28.
18. Kim JH Li H Stallcup MR. CoCoA, a nuclear receptor coactivator which acts through an N-terminal activation domain of p160 coactivators. Mol Cell 2003 12 1537 49.
19. Shiau AK Barstad D Loria PM Cheng L Kushner PJ Agard DA et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998 95 927 37.
20. Brzozowski AM Pike AC Dauter Z Hubbard RE Bonn T Engstrom O et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997 389 753 8.
21. Spencer TE Jenster G Burcin MM Allis CD Zhou J Mizzen CA et al. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 1997 389 194 8.
22. Chen D Ma H Hong H Koh SS Huang SM Schurter BT et al. Regulation of transcription by a protein methyltransferase. Science 1999 284 2174 7.
23. Koh SS Chen D Lee YH Stallcup MR. Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem 2001 276 1089 98.
24. Gnanapragasam VJ Leung HY Pulimood AS Neal DE Robson CN. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer. Br J Cancer 2001 85 1928 36.
25. Zhou HJ Yan J Luo W Ayala G Lin SH Erdem H et al. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res 2005 65 7976 83.
26. Tanner MM Grenman S Koul A Johannsson O Meltzer P Pejovic T et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000 6 1833 9.
27. Carroll RS Brown M Zhang J DiRenzo J De Mora JF Black PM. Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas. Clin Cancer Res 2000 6 3570 5.
28. List HJ Reiter R Singh B Wellstein A Riegel AT. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue. Breast Cancer Res Treat 2001 68 21 8.
29. Bouras T Southey MC Venter DJ. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res 2001 61 903 7.
30. Osborne CK Bardou V Hopp TA Chamness GC Hilsenbeck SG Fuqua SA et al. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 2003 95 353 61.
31. Shou J Massarweh S Osborne CK Wakeling AE Ali S Weiss H et al. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J Natl Cancer Inst 2004 96 926 35.
32. Reiter R Wellstein A Riegel AT. An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer. J Biol Chem 2001 276 39736 41.
33. Henke RT Haddad BR Kim SE Rone JD Mani A Jessup JM et al. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clin Cancer Res 2004 10 6134 42.
34. Ghadimi BM Schrock E Walker RL Wangsa D Jauho A et al. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am J Pathol 1999 154 525 36.
35. Sakakura C Hagiwara A Yasuoka R Fujita Y Nakanishi M Masuda K et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer 2000 89 217 23.
36. Xie D Sham JS Zeng WF Lin HL Bi J Che LH et al. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma. Hum Pathol 2005 36 777 83.
37. Wang Y Wu MC Sham JS Zhang W Wu WQ Guan XY. Prog nostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer 2002 95 2346 52.
38. Torres-Arzayus MI De Mora JF Yuan J Vazquez F Bronson R Rue M et al. High tumor incidence and activation of the PI3K/ AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 2004 6 263 74.
39. Tilli MT Reiter R Oh AS Henke RT McDonnell K Gallicano GI et al. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice. Mol Endocrinol 2005 19 644 56.
40. Xu J Liao L Ning G Yoshida-Komiya H Deng C O'Malley BW. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci USA 2000 97 6379 84.
41. Wang Z Rose DW Hermanson O Liu F Herman T Wu W et al. Regulation of somatic growth by the p160 coactivator p/CIP. Proc Natl Acad Sci USA 2000 97 13549 54.
42. Kuang SQ Liao L Zhang H Lee AV O'Malley BW Xu J. AIB1/ SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice. Cancer Res 2004 64 1875 85.
43. Kuang SQ Liao L Wang S Medina D O'Malley BW Xu J. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. Cancer Res 2005 65 7993 8002.
44. Azorsa DO Cunliffe HE Meltzer PS. Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells. Breast Cancer Res Treat 2001 70 89 101.
45. List HJ Lauritsen KJ Reiter R Powers C Wellstein A Riegel AT. Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells. J Biol Chem 2001 276 23763 8.
46. Shao W Keeton EK McDonnell DP Brown M. Coactivator AIB1 links estrogen receptor transcriptional activity and stability. Proc Natl Acad Sci USA 2004 101 11599 604.
47. Planas-Silva MD Shang Y Donaher JL Brown M Weinberg RA. AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res 2001 61 3858 62.
48. Reiter R Oh AS Wellstein A Riegel AT. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity. Oncogene 2004 23 403 9.
49. Harbour JW Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 2000 14 2393 409.
50. Dimova DK Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005 24 2810 26.
51. Hunt KK Keyomarsi K. Cyclin E as a prognostic and predictive marker in breast cancer. Semin Cancer Biol 2005 15 319 26.
52. Keyomarsi K Tucker SL Buchholz TA Callister M Ding Y Hortobagyi GN et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002 347 1566 75.
53. Han S Park K Bae BN Kim KH Kim HJ Kim YD et al. E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide. Breast Cancer Res Treat 2003 82 11 6.
54. Dhillon NK Mudryj M. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. Oncogene 2002 21 4626 34.
55. Grimberg A. Mechanisms by which IGF-I may promote cancer. Cancer Biol Ther 2003 2 630 5.
56. Oh A List HJ Reiter R Mani A Zhang Y Gehan E et al. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells. Cancer Res 2004 64 8299 308.
57. Zhou G Hashimoto Y Kwak I Tsai SY Tsai MJ. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol Cell Biol 2003 23 7742 55.
58. Lin A Karin M. NF-κB in cancer: a marked target. Semin Cancer Biol 2003 13 107 14.
59. Werbajh S Nojek I Lanz R Costas MA. RAC-3 is an NF-kappa B coactivator. FEBS Lett 2000 485 195 9.
60. Wu RC Qin J Hashimoto Y Wong J Xu J Tsai SY et al. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase. Mol Cell Biol 2002 22 3549 61.
61. Pages F Vives V Sautes-Fridman C Fossiez F Berger A Cugnenc PH et al. Control of tumor development by intratumoral cytokines. Immunol Lett 1999 68 135 9.
62. Giri D Ozen M Ittmann M. Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol 2001 159 2159 65.
63. Shariat SF Andrews B Kattan MW Kim J Wheeler TM Slawin KM. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urol ogy 2001 58 1008 15.
64. Wu RC Qin J Yi P Wong J Tsai SY Tsai MJ et al. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Mol Cell 2004 15 937 49.
65. Wu RC Smith CL O'Malley BW. Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocrine Rev 2005 26 393 9.
66. Raught B Liao WSL Rosen JM. Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression. Mol Endocrinol 1995 9 1223 32.
67. Kagan BL Henke RT Cabal-Manzano R Stoica GE Nguyen Q Wellstein A et al. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta. Cancer Res 2003 63 1696 705.
68. Font de Mora J Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 2000 20 5041 7.
69. Goel A Janknecht R. Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu. J Biol Chem 2004 279 14909 16.